Details of the Drug Reposition

General Information of This Drug (ID: DMSRIT4)

Drug Name
Lenzilumab   DMSRIT4
Synonyms lenzilumab; GTPL8935; KB003; KB-003
Therapeutic Class
Antiviral Agents
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Coronavirus Disease 2019 (COVID-19) DISM7GNX 1D6Y Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic myelogenous leukaemia DIS0301E 2A20.0 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04583969) ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)